According to IMARC Group’s latest report, titled “Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global protein therapeutics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Protein therapeutics are medicinal drugs utilized to treat cancer, diabetes, and neurodegenerative and other disorders. These drugs allow an individualized treatment approach by compensating for the deficiency of an essential protein. Consequently, they are gaining immense popularity around the world.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.
Get a free sample copy of this report: https://www.imarcgroup.com/protein-therapeutics-market/requestsample
Market Trends and Drivers:
The increasing instances of chronic diseases, in confluence with the development of plasma-derived therapies, represent one of the key factors impelling the global protein therapeutics market growth. Apart from this, governments of different countries are undertaking numerous initiatives for the development of a modernized healthcare system. This, in turn, is increasing the sales of protein therapeutics worldwide. Moreover, the rising awareness among the masses about the benefits of protein therapeutics, such as high efficiency and minimal side effects, are propelling the market growth. Furthermore, the rising cases of coronavirus disease (COVID-19) are creating a positive impact on the protein therapeutics market as they are finding is widely adopting these medicines.
Protein Therapeutics Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the protein therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Biogen Inc.
- Johnson & Johnson
- Abbott Laboratories
- Csl Behring L.L.C. (CSL Limited)
- Abbvie Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Merck & Co. Inc.
- Novo Nordisk A/S (Novo Holdings A/S)
- Baxter International Inc.
Key Market Segmentation:
The report has segmented the global protein therapeutics market on the basis of product, therapy area, function and region.
Breakup by Product:
- Monoclonal Antibodies (mAbs)
- Human Insulin
- Clotting Factors
- Fusion Protein
Breakup by Therapy Area:
- Metabolic Disorders
- Immunological Disorders
- Hematological Disorders
- Hormonal Disorders
- Genetic Disorders
Breakup by Function:
- Enzymatic and Regulatory Activity
- Special Targeting Activity
- Protein Diagnostics
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Buy full report with table of contents: https://www.imarcgroup.com/protein-therapeutics-market
Key Highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Osteoarthritis Therapeutics Market Report: https://www.imarcgroup.com/osteoarthritis-therapeutics-market
Foot and Mouth Disease Vaccine Market Report: https://www.imarcgroup.com/foot-mouth-disease-vaccine-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800